Selma Emre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Selma Emre has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Ahmet Metin
5 shared publicationsDuriye Deniz Demirseren
Department of Dermatology, Ataturk Training and Research Hospital, Ankara, Turkey
4 shared publications- Duriye Deniz Demirseren
Department of Dermatology and Venereology University of Health Sciences, Ankara Bilkent City Hospital Ankara Turkey
4 shared publications Ozcan Erel
B Department of Biochemistry , Yıldırım Beyazıt University, Medical School, Atatürk Training and Research Hospital , Ankara , Turkey
4 shared publications- Ayse Serap Karadag
Department of Dermatology Memorial Atasehir Hospital Istanbul Turkey
3 shared publications - Esra Adışen
Department of Dermatology Gazi University Faculty of Medicine Ankara Türkiye
3 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (9) , 1584-1594
Biologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety
Real-world evidence regarding biologic therapy in geriatric psoriasis is limited, particularly concerning systemic inflammatory burden and infection-related safety. This study evaluates the clinical efficacy of biologic therapy and its impact on systemic inflammatory indices while emphasizing safety related to hepatitis B virus (HBV) serology and tuberculosis screening. We conducted a retrospective analysis of eighty biologic-naïve patients aged 65 years and older with plaque psoriasis undergoing biologic therapy. Patients were categorized by biologic class: tumor necrosis factor-α (TNF-α) inhibitors, interleukin-17 inhibitors, an interleukin-12/23 inhibitor, and interleukin-23 inhibitors. The primary outcomes included changes in Psoriasis Area and Severity Index (PASI) scores and blood count-derived inflammatory indices over time (baseline and 6 months). Secondary outcomes encompassed changes in HBV serologic status and QuantiFERON-TB (QFT) results. Data analysis utilized longitudinal mixed-effects models for repeated measures. Blood count-derived inflammatory indices, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), were assessed at baseline and 6 months, alongside HBV serology and QFT results. PASI scores demonstrated significant improvement over time (p < 0.001), with no notable differences among biologic classes after adjusting for baseline covariates. Significant time effects were observed for all inflammatory indices (all p < 0.001), with significant group × time interactions noted for SII and NLR (both p < 0.05). Variability in HBV serologic markers and QFT results was observed during follow-up; however, no cases of active tuberculosis or clinically overt hepatitis were identified. In conclusion, biologic therapy led to substantial clinical improvement in geriatric psoriasis, accompanied by reductions in systemic inflammatory indices over a 6-month period, without evidence of clinically overt hepatitis or active tuberculosis during follow-up.
- 4 March 2026
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (9) , 1584-1594
Open AccessBiologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety
Real-world evidence regarding biologic therapy in geriatric psoriasis is limited, particularly concerning systemic inflammatory burden and infection-related safety. This study evaluates the clinical efficacy of biologic therapy and its impact on systemic inflammatory indices while emphasizing safety related to hepatitis B virus (HBV) serology and tuberculosis screening. We conducted a retrospective analysis of eighty biologic-naïve patients aged 65 years and older with plaque psoriasis undergoing biologic therapy. Patients were categorized by biologic class: tumor necrosis factor-α (TNF-α) inhibitors, interleukin-17 inhibitors, an interleukin-12/23 inhibitor, and interleukin-23 inhibitors. The primary outcomes included changes in Psoriasis Area and Severity Index (PASI) scores and blood count-derived inflammatory indices over time (baseline and 6 months). Secondary outcomes encompassed changes in HBV serologic status and QuantiFERON-TB (QFT) results. Data analysis utilized longitudinal mixed-effects models for repeated measures. Blood count-derived inflammatory indices, such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), were assessed at baseline and 6 months, alongside HBV serology and QFT results. PASI scores demonstrated significant improvement over time (p < 0.001), with no notable differences among biologic classes after adjusting for baseline covariates. Significant time effects were observed for all inflammatory indices (all p < 0.001), with significant group × time interactions noted for SII and NLR (both p < 0.05). Variability in HBV serologic markers and QFT results was observed during follow-up; however, no cases of active tuberculosis or clinically overt hepatitis were identified. In conclusion, biologic therapy led to substantial clinical improvement in geriatric psoriasis, accompanied by reductions in systemic inflammatory indices over a 6-month period, without evidence of clinically overt hepatitis or active tuberculosis during follow-up.
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Evaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study
Introduction: Calcitonin gene–related peptide (CGRP) is a vasoactive neuropeptide implicated in the neurovascular dysregulation and neurogenic inflammation involved in rosacea pathogenesis. However, evidence regarding circulating CGRP levels in rosacea remains limited. Therefore, this study aimed to compare serum CGRP levels between patients with rosacea and healthy controls and to investigate their associations with rosacea severity, subtype, and Demodex positivity. Methods: Fifty‐five patients with rosacea and 55 age‐ and sex‐matched healthy controls were included in the study. Peripheral blood samples were analyzed for serum CGRP levels using enzyme‐linked immunosorbent assay (ELISA). Disease severity was evaluated using the Rosacea Area and Severity Index (RASI). Demodex density was assessed using the standardized skin surface biopsy technique, and group comparisons were performed. Results: Serum CGRP levels were significantly lower in patients with rosacea than in healthy controls (4.66 [IQR: 2.93–11.7] vs. 11.1 [IQR: 7.14–79.4] pg/mL, p < 0.001). No significant differences in serum CGRP levels were observed according to rosacea subtype, disease severity, or Demodex positivity ( p > 0.05 for all). In addition, serum CGRP levels did not correlate with RASI scores, Demodex density, or disease duration ( p > 0.05 for all). Conclusion: The findings suggest that circulating serum CGRP levels may not adequately reflect local cutaneous neurogenic and neurovascular activity in rosacea. The lack of association between serum CGRP levels and clinical severity, rosacea subtype, or Demodex positivity further supports the possibility that local cutaneous CGRP dysregulation may be more relevant than systemic circulating levels in rosacea pathogenesis. Further studies integrating both serum and tissue‐level analyses are needed to clarify the role of CGRP in rosacea pathogenesis.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessEvaluation of CGRP Levels in Patients With Rosacea: A Prospective Case–Control Study
Introduction: Calcitonin gene–related peptide (CGRP) is a vasoactive neuropeptide implicated in the neurovascular dysregulation and neurogenic inflammation involved in rosacea pathogenesis. However, evidence regarding circulating CGRP levels in rosacea remains limited. Therefore, this study aimed to compare serum CGRP levels between patients with rosacea and healthy controls and to investigate their associations with rosacea severity, subtype, and Demodex positivity. Methods: Fifty‐five patients with rosacea and 55 age‐ and sex‐matched healthy controls were included in the study. Peripheral blood samples were analyzed for serum CGRP levels using enzyme‐linked immunosorbent assay (ELISA). Disease severity was evaluated using the Rosacea Area and Severity Index (RASI). Demodex density was assessed using the standardized skin surface biopsy technique, and group comparisons were performed. Results: Serum CGRP levels were significantly lower in patients with rosacea than in healthy controls (4.66 [IQR: 2.93–11.7] vs. 11.1 [IQR: 7.14–79.4] pg/mL, p < 0.001). No significant differences in serum CGRP levels were observed according to rosacea subtype, disease severity, or Demodex positivity ( p > 0.05 for all). In addition, serum CGRP levels did not correlate with RASI scores, Demodex density, or disease duration ( p > 0.05 for all). Conclusion: The findings suggest that circulating serum CGRP levels may not adequately reflect local cutaneous neurogenic and neurovascular activity in rosacea. The lack of association between serum CGRP levels and clinical severity, rosacea subtype, or Demodex positivity further supports the possibility that local cutaneous CGRP dysregulation may be more relevant than systemic circulating levels in rosacea pathogenesis. Further studies integrating both serum and tissue‐level analyses are needed to clarify the role of CGRP in rosacea pathogenesis.
- 3 May 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (11) , 1356-1361
The reliability and quality of YouTube videos about isotretinoin treatment and suicide
Background: Seeking health information online has drastically increased. Isotretinoin is one of the agents used to treat acne. Objectives: In this study, we aimed to investigate the reliability and quality of YouTube videos related to acne treatment. There is a misconception that use of isotretinoin increases risk of suicide. Methods: We used the terms ‘isotretinoin suicide’ and ‘acne treatment suicide’ to search YouTube videos. Videos that were not in English, were irrelevant, or were devoid of audio were not included. The information in the videos was primarily categorized as ‘reliable’ or ‘unreliable’ based on its scientific validation. DISCERN and the Global Quality Score were used to evaluate the videos’ overall quality. Results: In total, 200 videos were examined and 112 videos were included in the study. Of these, 39 videos (34.8%) were found to be reliable, and 73 videos (65.2%) were found to be unreliable. The DISCERN values of videos uploaded by physicians or professional organizations, and health information websites were found to be significantly higher. There were statistically significant negative correlations between DISCERN score and both video length and the length of time the video was on YouTube, while a positive correlation was observed between DISCERN score and the number of subscribers. Conclusions: Although videos created by dermatologists have become widespread in recent years, they are still insufficient. Patient experience videos mostly contain information that does not reflect reality, and they emphasize that isotretinoin increases the risk of suicide without evidence. As the number of dermatologists posting videos on YouTube increases, the chances of people accessing correct information will increase.
- 3 May 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (11) , 1356-1361
The reliability and quality of YouTube videos about isotretinoin treatment and suicide
Background: Seeking health information online has drastically increased. Isotretinoin is one of the agents used to treat acne. Objectives: In this study, we aimed to investigate the reliability and quality of YouTube videos related to acne treatment. There is a misconception that use of isotretinoin increases risk of suicide. Methods: We used the terms ‘isotretinoin suicide’ and ‘acne treatment suicide’ to search YouTube videos. Videos that were not in English, were irrelevant, or were devoid of audio were not included. The information in the videos was primarily categorized as ‘reliable’ or ‘unreliable’ based on its scientific validation. DISCERN and the Global Quality Score were used to evaluate the videos’ overall quality. Results: In total, 200 videos were examined and 112 videos were included in the study. Of these, 39 videos (34.8%) were found to be reliable, and 73 videos (65.2%) were found to be unreliable. The DISCERN values of videos uploaded by physicians or professional organizations, and health information websites were found to be significantly higher. There were statistically significant negative correlations between DISCERN score and both video length and the length of time the video was on YouTube, while a positive correlation was observed between DISCERN score and the number of subscribers. Conclusions: Although videos created by dermatologists have become widespread in recent years, they are still insufficient. Patient experience videos mostly contain information that does not reflect reality, and they emphasize that isotretinoin increases the risk of suicide without evidence. As the number of dermatologists posting videos on YouTube increases, the chances of people accessing correct information will increase.
- 26 December 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (7) , E596-E598
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group
- 26 December 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (7) , E596-E598
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group
- Open Access
- 29 April 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (2) , e2023134
Investigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients with Psoriasis
Introduction: Psoriasis is an immune-mediated, chronic and inflammatory disease whose pathogenesis is affected by the interactions of several immune cells and cytokines. PD-1 is an inhibitor receptor that is expressed to a large extent in T lymphocytes and responsible for regulating autoimmunity and self-tolerance. Objectives: In this study, we aimed to investigate the expression of PD-1/PD-L molecules in the lesioned skins of psoriasis patients. Methods: The study included 30 psoriasis patients, and 15 healthy volunteers as the control group. Anti PD-1 and PD-L1 antibodies were applied to the skin biopsy samples that were collected from the patient and control groups. Cytoplasmic and membranous staining of PD-1 and PD-L1 were considered positive. The number of stained immune cells that was examined for each case. Results: The percentage of the tissues with high PD-1 (+) and PDL-1 (+) immune cell counts were significantly higher in the psoriasis patients compared to healthy controls (P values = 0.004 and 0.002, respectively). A negative and statistically significant correlation was detected between PDL-1(+) immune cell numbers and PASI scores (P = 0.033, r=-0.57). Conclusions: In the lesioned skin samples of psoriasis patients, the PD-1 and PD-L1 expressions were significantly higher in immune cells than that in the skin samples of the healthy controls. This study was the first investigation of the expression of PD-1/PD-L molecules in the immune cells in found the lesioned skins of psoriasis patients.
- 29 April 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (2) , e2023134
Open AccessInvestigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients with Psoriasis
Introduction: Psoriasis is an immune-mediated, chronic and inflammatory disease whose pathogenesis is affected by the interactions of several immune cells and cytokines. PD-1 is an inhibitor receptor that is expressed to a large extent in T lymphocytes and responsible for regulating autoimmunity and self-tolerance. Objectives: In this study, we aimed to investigate the expression of PD-1/PD-L molecules in the lesioned skins of psoriasis patients. Methods: The study included 30 psoriasis patients, and 15 healthy volunteers as the control group. Anti PD-1 and PD-L1 antibodies were applied to the skin biopsy samples that were collected from the patient and control groups. Cytoplasmic and membranous staining of PD-1 and PD-L1 were considered positive. The number of stained immune cells that was examined for each case. Results: The percentage of the tissues with high PD-1 (+) and PDL-1 (+) immune cell counts were significantly higher in the psoriasis patients compared to healthy controls (P values = 0.004 and 0.002, respectively). A negative and statistically significant correlation was detected between PDL-1(+) immune cell numbers and PASI scores (P = 0.033, r=-0.57). Conclusions: In the lesioned skin samples of psoriasis patients, the PD-1 and PD-L1 expressions were significantly higher in immune cells than that in the skin samples of the healthy controls. This study was the first investigation of the expression of PD-1/PD-L molecules in the immune cells in found the lesioned skins of psoriasis patients.
- Open Access
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022190
Patient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients
Background: Due to the chronic, recurrent nature of Psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. Objectives: To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. Methods: The patients’ sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients’ CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. Results: Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI score,s and DLQI of those using CAM were significantly higher. CAM use were significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. Conclusions: Patients’ CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022190
Open AccessPatient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients
Background: Due to the chronic, recurrent nature of Psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. Objectives: To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. Methods: The patients’ sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients’ CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. Results: Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI score,s and DLQI of those using CAM were significantly higher. CAM use were significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. Conclusions: Patients’ CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.
- 13 April 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (8) , 1256-1265
Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: a multicentre case series
Background: Generalized pustular psoriasis (GPP) is a rare and severe inflammatory disease characterized by widespread and superficial sterile pustules on an erythematous background.Objectives: This multicentre study aimed to determine the clinical profile and course in a large cohort of patients with GPP.Methods: One hundred and fifty‐six GPP patients (mean age, 44.2 ± 18.7 years) who met the diagnostic criteria of the European Consensus Report of GPP were included in the study. Sociodemographic characteristics, quality of life, triggering factors of the disease, clinical, laboratory, treatment and prognostic features were evaluated.Results: 61.5% of the patients were female. The rate of working at or below the minimum wage (≤$332.5/month) was 44.9%. Drugs (36.5%) were the most common trigger. While hypocalcaemia (35.7%) was the most important cause of GPP during pregnancy, systemic steroid withdrawal (20%) was the most frequently reported trigger for infantile/juvenile and mixed‐type GPP (15%) (P < 0.05). Acute GPP (53.8%) was the most common clinic. Nails were affected in 43.6% of patients, and subungual yellow spots (28.2%) were the most common change. In annular GPP, fever (P < 0.001) and relapse frequency (P = 0.006) were lower than other subtypes, and the number of hospitalizations (P = 0.002) was lower than acute GPP. GPP appeared at a later age in those with a history of psoriasis (P = 0.045). DLQI score (P = 0.049) and joint involvement (P = 0.016) were also higher in this group. Infantile/juvenile GPP was observed in 16.02% of all patients, and arthritis was lower in this group (24.4 vs. 16%). GPP of pregnancy had the worst prognosis due to abortion observed in three patients.Conclusions: Recent advances in treatment have improved mortality associated with GPP, but abortion remains a significant complication. Although TNF‐α inhibitors have proven efficacy in GPP, they can also trigger the disease. Mixed‐type GPP is more similar to acute GPP than annular GPP with systemic manifestations and course.
- 13 April 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (8) , 1256-1265
Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: a multicentre case series
Background: Generalized pustular psoriasis (GPP) is a rare and severe inflammatory disease characterized by widespread and superficial sterile pustules on an erythematous background.Objectives: This multicentre study aimed to determine the clinical profile and course in a large cohort of patients with GPP.Methods: One hundred and fifty‐six GPP patients (mean age, 44.2 ± 18.7 years) who met the diagnostic criteria of the European Consensus Report of GPP were included in the study. Sociodemographic characteristics, quality of life, triggering factors of the disease, clinical, laboratory, treatment and prognostic features were evaluated.Results: 61.5% of the patients were female. The rate of working at or below the minimum wage (≤$332.5/month) was 44.9%. Drugs (36.5%) were the most common trigger. While hypocalcaemia (35.7%) was the most important cause of GPP during pregnancy, systemic steroid withdrawal (20%) was the most frequently reported trigger for infantile/juvenile and mixed‐type GPP (15%) (P < 0.05). Acute GPP (53.8%) was the most common clinic. Nails were affected in 43.6% of patients, and subungual yellow spots (28.2%) were the most common change. In annular GPP, fever (P < 0.001) and relapse frequency (P = 0.006) were lower than other subtypes, and the number of hospitalizations (P = 0.002) was lower than acute GPP. GPP appeared at a later age in those with a history of psoriasis (P = 0.045). DLQI score (P = 0.049) and joint involvement (P = 0.016) were also higher in this group. Infantile/juvenile GPP was observed in 16.02% of all patients, and arthritis was lower in this group (24.4 vs. 16%). GPP of pregnancy had the worst prognosis due to abortion observed in three patients.Conclusions: Recent advances in treatment have improved mortality associated with GPP, but abortion remains a significant complication. Although TNF‐α inhibitors have proven efficacy in GPP, they can also trigger the disease. Mixed‐type GPP is more similar to acute GPP than annular GPP with systemic manifestations and course.
- Open Access
- 16 February 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (5) , e15369
The case of granuloma annulare associated with SARS‐CoV ‐2 infection
- 16 February 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (5) , e15369
Open AccessThe case of granuloma annulare associated with SARS‐CoV ‐2 infection
- 1 January 2022
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 16 (2) , 71-72
Skin reaction due to UVC radiation used to inactivate SARS-CoV-2 virus
Turkish Journal of Dermatology, Turkish Society of Dermatology
- 1 January 2022
- Published by Galenos Yayinevi in Turkish Journal of Dermatology
- Vol. 16 (2) , 71-72
Skin reaction due to UVC radiation used to inactivate SARS-CoV-2 virus
Turkish Journal of Dermatology, Turkish Society of Dermatology
- Open Access
- 1 January 2020
- Published by XMLink in Annals of Dermatology
- Vol. 32 (3) , 181-188
Internalized Stigma in Pediatric Psoriasis: A Comparative Multicenter Study
Alpsoy E, et al. Ann Dermatol. 2020 Jun;32(3):181-188. https://doi.org/10.5021/ad.2020.32.3.181
- 1 January 2020
- Published by XMLink in Annals of Dermatology
- Vol. 32 (3) , 181-188
Open AccessInternalized Stigma in Pediatric Psoriasis: A Comparative Multicenter Study
Alpsoy E, et al. Ann Dermatol. 2020 Jun;32(3):181-188. https://doi.org/10.5021/ad.2020.32.3.181